Top 3 Australian Growth Stocks With Revenue Growth Up To 52%

Global markets have just been reminded how quickly enthusiasm for themes like artificial intelligence can reverse, with European shares sliding as investors reassess richly priced growth stories. That kind of shakeout can push Australian high growth companies with meaningful insider ownership into sharper focus. This article walks through three such locally listed stocks where management has significant skin in the game and analysts have identified potential for business expansion.

The three stocks highlighted here offer a compelling starting point if you want exposure to fast growing businesses where insiders are strongly aligned with outside shareholders. However, if you want the strongest names, these 27 high growth high conviction stocks are the top of the list.

PDI Gold (ASX:PDI)

Overview: PDI Gold is a West African gold group focused on exploring, developing, mining and processing deposits, with the Kiniéro Gold Mine as its flagship growth engine.

Operations: The business currently derives about US$156 million from Kiniéro and US$47 million from Nampala, highlighting Kiniéro as the primary revenue driver.

Market Cap: A$4.4 billion

PDI Gold is relevant for this high growth, high insider alignment theme because its Kiniéro development and refining business directly links operational progress to potential step changes in future earnings.

"The cash and bullion position reported at about US$530m by June 2026 and US$364m by late September 2026 against US$130m of debt creates scope for PDI Gold to self fund a larger portion of Bankan and other growth options, which can limit future financing costs and support net margins."

This raises a key question: what happens if one quiet assumption about how quickly those extra tonnes translate into sustained margin strength proves either too optimistic or too cautious?

If that assumption matters to your thesis, read the full narrative for PDI Gold to see how insider alignment could accelerate or stall the next phase.

Telix Pharmaceuticals (ASX:TLX)

Overview: Telix Pharmaceuticals develops and sells radiopharmaceutical diagnostics and therapies that help doctors precisely image and target cancers such as prostate, brain and kidney.

Operations: Telix generates about US$705 million from Precision Medicine and US$277 million from Manufacturing Solutions, with most revenue earned in the United States.

Market Cap: A$4.6 billion

Telix Pharmaceuticals fits this fast growth, high insider ownership theme through its radiopharmaceutical precision medicine pipeline, where late-stage prostate cancer programs anchor management’s push to scale recurring diagnostic and therapeutic revenue.

"Their primary revenue generating imaging agents: 'Illuccix' and 'Gozellix', are utilised in 23+ countries worldwide, including key markets such as the U.S, Europe, China and Japan, with revenue figures of $803.8m (USD) in the 2025 Financial Year (within their already upgraded guidance range) provided for FY25, a cash balance of $141.9m (USD), and the potential growth of Gozellix as its launch into the U.S expands."

What matters now is how one unresolved pressure around funding and late-stage trial outcomes ultimately flows through to margins and growth visibility.

That funding question is the real pivot, and the full narrative for Telix Pharmaceuticals explains in detail how Telix Pharmaceuticals could convert today's imaging footprint into accelerating cash generation or a frustratingly stalled opportunity.

Codan (ASX:CDA)

Overview: Codan designs and sells communications systems and metal detectors, with its radio networks directly linked to growing defense and emergency markets.

Operations: Codan generates about A$506 million from Communications and A$362 million from Metal Detection, with sales spread across global government and commercial customers.

Market Cap: A$9.9 billion

Codan matters for a high growth, high insider alignment theme because its Communications arm ties real contracts in defense, security and emergency services to management’s confidence about compounding earnings power.

"Heightened defense and security demand for unmanned and secure communications, reflected in approximately $215m of unmanned revenue in FY26 and a Communications order book of $380m that is 50% higher year on year, points to further growth potential in segment revenue and earnings if these orders continue to convert."

The weight of that opportunity ultimately hinges on how one quiet constraint shapes the pace at which future demand turns into durable profit growth.

If that constraint is what you keep circling back to, the full narrative for Codan explains how Codan could use today’s order book to build accelerating, longer term earnings power.

Seeking Alternatives Before Momentum Flies

Fresh ideas move first. Once a breakout gets caught by the crowd, entry points shrink fast and information value drops. Scan these focused lists now and aim to participate earlier in the move.

• Explore potential income momentum by reviewing a curated group of companies screened as 5 dividend fortresses before yields or prices move away from today’s setup.
• Follow where AI spending may be developing by checking the hand picked 52 AI infrastructure stocks while these infrastructure ideas are still less widely followed.
• Consider positioning for possible electrification trends by scanning the refined 16 top copper producer stocks before momentum traders focus on the same producers.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com